Which of the following statements about hyperthyroidism treatment is incorrect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Statement B is INCORRECT: Radioactive iodine is a well-established and widely used treatment for hyperthyroidism

Radioactive iodine (RAI) therapy is one of the three primary treatment modalities for hyperthyroidism, particularly Graves' disease, and is explicitly recommended in major clinical guidelines 1, 2.

Analysis of Each Statement

A) Beta-blockers for symptomatic treatment - CORRECT

Beta-adrenergic blockade is strongly recommended for symptomatic management of thyrotoxicosis 1. Specifically:

  • Should be given to elderly patients with symptomatic thyrotoxicosis
  • Required for patients with resting heart rates >90 bpm or cardiovascular disease
  • Should be considered in all symptomatic patients to control adrenergic symptoms (palpitations, tremor, anxiety)

B) Radioactive iodine not indicated - INCORRECT

This statement is false. RAI is explicitly recommended as one of three equally acceptable first-line treatments for Graves' hyperthyroidism 1, 2. The 2011 ATA/AACE guidelines state that "patients with overt Graves' hyperthyroidism should be treated with any of the following modalities: 131I therapy, antithyroid medication, or thyroidectomy" 1.

RAI is particularly indicated for:

  • Females planning pregnancy >4-6 months in the future
  • Patients with comorbidities increasing surgical risk
  • Previously operated or irradiated necks
  • Contraindications to antithyroid drugs
  • Toxic multinodular goiter or toxic adenoma

RAI is contraindicated in:

  • Pregnancy and lactation
  • Females planning pregnancy within 4-6 months
  • Coexisting or suspected thyroid cancer
  • Inability to comply with radiation safety guidelines 1

C) Thyroidectomy before conception - CORRECT

Surgery is specifically recommended for females planning pregnancy in <4-6 months (before thyroid hormone levels would normalize with RAI) 1. This timing is critical because:

  • RAI requires 4-6 months for thyroid function to stabilize
  • Pregnancy must be avoided during this period
  • Surgery provides definitive, rapid control before conception
  • Particularly important when TSH-receptor antibody levels are high

D) Thiamazole (methimazole) as treatment of choice - CORRECT

Methimazole should be used in virtually every patient choosing antithyroid drug therapy 1. The guideline explicitly states this is the preferred ATD in the majority of cases, with specific exceptions noted below.

E) Methimazole contraindicated in first trimester - CORRECT

Methimazole should NOT be administered during the first trimester of pregnancy 1, 3. The guidelines clearly state:

  • Propylthiouracil (PTU) is preferred during the first trimester
  • Women should be switched from methimazole to PTU when planning pregnancy
  • This is due to methimazole's association with congenital anomalies (aplasia cutis, choanal atresia, esophageal atresia)
  • PTU should be used despite its hepatotoxicity risk during this critical period

Key Clinical Pitfalls

Common misconception about RAI: Some clinicians incorrectly believe RAI is contraindicated or not recommended for hyperthyroidism. In reality, it has been used safely for six decades and is one of three equally acceptable first-line treatments 1.

Timing considerations: The 4-6 month waiting period after RAI before conception is critical and often determines whether surgery is the better option for women of childbearing age planning pregnancy soon 1.

ATD selection in pregnancy: The switch from methimazole to PTU must occur before conception and only during the first trimester, with a switch back to methimazole in the second trimester to minimize PTU hepatotoxicity risk 3.

References

1
Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Related Questions

Please provide a prescription for treating hyperthyroidism.
What is the appropriate initial workup for a 32-year-old female with hyperthyroidism?
What are the neuromuscular manifestations of hyperthyroidism?
What are the causes, clinical features, diagnosis, and management of hyperthyroidism?
Could hyperthyroidism be related to the described symptom pattern?
In a patient with macrocytic anemia, low hemoglobin, low red blood cell count, low serum iron, high ferritin, low total iron‑binding capacity, and elevated mean corpuscular volume, what is the most likely diagnosis and what is the appropriate management?
What are the effect-site equilibration constants (Ke0) for the propofol pharmacokinetic models used in total intravenous anesthesia (TIVA)?
What is the tolerable range of femoral component antiversion in total hip replacement?
For a 26‑year‑old patient with pubalgia, is platelet‑rich plasma (PRP) injection into the left internal obturator insertion an appropriate treatment, and what protocol would you recommend?
Given a patient with macrocytic anemia (hemoglobin 9.8 g/dL, MCV 107 fL), low serum iron, low total iron‑binding capacity, elevated ferritin, normal vitamin B12 and folate, and a low‑normal free thyroxine with normal thyroid‑stimulating hormone, what is the most likely diagnosis and appropriate management?
Is there an outpatient (ambulatory) management approach for a psoas abscess?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.